IRVINE, Calif.--(BUSINESS WIRE)--Immunis, Inc., a clinical-stage biotech developing multi-active biologics for age and disease-related immune dysregulation, announces that it has initiated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback